Indonesian Pharma to Lobby for Foreign Direct Investments Incentives

JAKARTA, Indonesia, Jan. 12, 2016 /PRNewswire/ -- Representatives of the Indonesian Pharma Industry declared that the government must offer incentives and widen the door to foreign direct investment in the country's pharmaceutical industry to reduce dependence on imported raw material for medicine.
JAKARTA, Indonesia, (informazione.it - comunicati stampa - salute e benessere)

JAKARTA, Indonesia, Jan. 12, 2016 /PRNewswire/ -- Representatives of the Indonesian Pharma Industry declared that the government must offer incentives and widen the door to foreign direct investment in the country's pharmaceutical industry to reduce dependence on imported raw material for medicine.

Photo - http://photos.prnewswire.com/prnh/20151230/318436
Logo - http://photos.prnewswire.com/prnh/20121014/HK92339LOGO-d

Meanwhile, in a bid to encourage the industry, the Investment Coordinating Board (BKPM) gauged a plan to allow foreign investors to hold more shares in pharmacy companies, from currently a maximum of 85 percent, to 100 percent.

The Indonesian Pharmaceutical Association (GP Farmasi) business development committee head Vincent Harijanto acknowledged that most raw material are imported to produce medicine. At the same time he is optimistic that the country can become a production base for such overseas manufacturers given its large market, including toll manufacturing.

Tailored to suit this fast changing industry, the 5th edition of CPhI South East Asia taking place during 6-8 April 2016 in Jakarta provides the must-attend trade exhibition where the regional pharma industry meets to leverage connections, knowledge and insight to spur business.

Indonesian Pharma to Lobby for Foreign Direct Investments Incentives

Sign up now to attend!

Indonesian Health Ministry data show that the number of pharmacy companies stood at 239 last year, up from 206 in 2013. GP Farmasi projected investment in the pharmacy sector to reach Rp 215 trillion (US$15.34 billion) by 2025. The sector itself had potentials worth up to Rp 700 trillion, which consisted of Rp 450 trillion for the domestic market and Rp 250 trillion in exports, by 2025.

The CPhI series of events drives growth and innovation in the global pharmaceutical industry, with leading exhibitions and online communities covering every step of the supply chain from drug discovery to finished dosage.

More than 100,000 visitors meet over 6,000 exhibitors at events in Europe, China, India, Japan, South East Asia, Russia, Brazil, Istanbul and Korea every year to exchange ideas, form alliances and conduct business on an international scale. CPhI also provides an online buyer & supplier directory at CPhI-Online.com.

Contact Person: Ivan Ferrari
Phone Number: +62 21 2930 5959 ext 138
Email: [email protected]


Ufficio Stampa
 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
Allegati
Slide ShowSlide Show
Non disponibili